About

Lyell Immunopharma stands out as a preferred workplace due to its advanced focus on reprogramming T-cell therapies to treat solid tumors, a pivotal area in medical science. Employees engage in cutting-edge research aimed at overcoming historical barriers in adoptive cell therapy, fostering a dynamic environment that encourages innovation and problem-solving. With a strong commitment to addressing significant unmet medical needs, working here offers the unique opportunity to contribute directly to potentially life-saving therapies while advancing one's career in a scientifically robust community.